A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089

Autophagy

Volumn 10, Issue 12, 2014, Pages 2346-2361

  Sharma, Khushboo ^a   Goehe, Rachel W ^b   Di, Xu ^b   Hicks, Mark Anthony ^a   Torti, Suzy V ^c   Torti, Frank M ^c   Harada, Hisashi ^a   Gewirtz, David A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Autophagy; Cytoprotective; Cytostatic; NSCLC; Radiation

Indexed keywords

ADENYLATE KINASE; PROTEIN P53; SEOCALCITOL; VITAMIN D; VITAMIN D RECEPTOR; ANTINEOPLASTIC AGENT; CALCITRIOL;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL AGING; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME PHOSPHORYLATION; GENE REPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER CELL LINE; NON SMALL CELL LUNG CANCER; RADIOSENSITIVITY; RADIOSENSITIZATION; ANALOGS AND DERIVATIVES; CARCINOMA, NON-SMALL-CELL LUNG; DRUG EFFECTS; GENETICS; LUNG NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CALCITRIOL; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA DAMAGE; HUMANS; LUNG NEOPLASMS; VITAMIN D;

EID: 84922143072     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/15548627.2014.993283     Document Type: Article

References (53)

1. Langer CJ. Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges. Oncology/Hematology 2012; 83: 130-44.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62(1): 10-29; PMID: 22237781
3. Saintigny P, Burger JA, Recent advances in non-small cell lung cancer biology and clinical management. Discov Med 2012; 13(71): 287-97; PMID: 22541616
4. Wintner LM, Giesinger JM, Zabernigg A, Sztankay M, Meraner V, Pall G, Hilbe W, Holzner B. Quality of life during chemotherapy in lung cancer patients: Results across different treatment lines. Br J Cancer 2013; 109(9): 2301-8; PMID: 24091620; http://dx.doi. org/10.1038/bjc.2013.585
5. Cai S, Shi A, Yu R, Zhu G. Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2014; 9: 17; PMID: 24410971; http://dx.doi.org/10.1186/1748- 717X-9-17
6. Bayman N, Blackhall F, McCloskey P, Taylor P, Faivre- Finn C. How can we optimize concurrent cheoradiotherapy for inoperable stage III non-small cell lung cancer? Lung Cancer 2014; n83(2): 117-25; PMID: 24373738; http://dx.doi.org/10.1016/j.lungcan. 2013.11.017
7. Hamamoto Y, Kataoka M, Nogami N, Kozuki T, Kato Y, Shinohara S, and Shinkai T. Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemotherapy. Jpn J Radiol 2012; 30(3): 249-54; PMID: 22311092; http://dx.doi. org/10.1007/s11604-011-0040-9
8. Sundaram S, Gewirtz DA. The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation. Radiat Res 1999; 152(5): 479-86; PMID: 10521924
9. Gewirtz DA, Gupta MS, Sundaram S. Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemotherapy and radiotherapy. Curr Med Chem Anticancer Agents 2002; 2(6): 683-90; PMID: 12678720; http://dx.doi.org/10.2174/1568011023353697
10. Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes PJ, Demidenko E, Binderup L, Gewirtz DA. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 2003; 9(6): 2350-6; PMID: 12796405
11. Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am 2012; 38(1): 161-78; PMID: 22525850; http://dx.doi.org/10.1016/j.rdc.2012. 03.014
12. Ramnath N, Kim S, Christenden PJ. Vitamin D and lung cancer. Expert Rev Respir Med 2011; 5(3): 305-9; PMID: 21702651; http://dx.doi.org/10.1586/ers.11.31
13. Trump DL, Muindi J, Faikh M, Yu WD, Johnson CS. Vitamin D compounds: Clinical development as cancer therapy and prevention agents. Anticancer Res 2006; 26(4A): 2551-6; PMID: 16886663
14. Srinivasan M, Parwani VA, Hershberger AP, Lenzner ED, Weissfeld LJ. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol 2011; 123(1-2): 30-6; PMID: 20955794
15. Kim HS, Chen G, King NA, Jeon KC, Christensen JP, Zhao L, Simpson RU, Thomas DG, Giordano TJ, Brenner DE, et al. Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung cancer 2012; 77(2): 265-71; PMID: 22564539; http://dx.doi. org/10.1016/j.lungcan.2012.04.010
16. Menezes RJ, Cheney RT, Husain A, Tretiakova M, Loewen G, Johnson CS, Jayaprakash V, Moysich KB, Salgia R, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 2008; 17(5): 1104-10; PMID: 18483332; http://dx.doi.org/10.1158/1055-9965.EPI-07-2713
17. Zhou W, Heist SR, Liu G, Asomaning K, Neuberg SD, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L et al. Circulating 25-Hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J ClinOncol 2007; 25(5): 479-85; PMID: 17290055; http://dx.doi.org/10.1200/JCO.2006.07.5358
18. Bristol ML, Di X, Beckman MJ, Wilson EN, Henderson SC, Maiti A, Fan Z, Gewirtz DA. Dual functions of autophagy in the response of breast tumor cells to radiation: Cytoprtective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D3. Autophagy 2012; 8(5): 739-53; PMID: 22498493; http://dx.doi.org/10.4161/auto. 19313
19. Wilson EN, Bristol ML, Di X, Maltese WA, Koterba K, Beckman MJ, Gewirtz DA. A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm Cancer 2011; 2(5): 272-85; PMID: 21887591; http://dx.doi.org/10.1007/s12672-011- 0081-7
20. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)- mediated actions of 1a, 25(OH)2vitamin D3: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 543-59; PMID: 21872797
21. Demasters G, Di X, Newsham I, Shiu R, Gewirtz DA. Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 2006; 5(11): 2786-97; PMID: 17121925
22. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer inst 2001; 93(10): 745-53; PMID: 11353784
23. Jones KR, Elmore LW, Jackson-Cook C, Demasters G, Povirk LF, Holt SE, Gewirtz DA. p53-dependent accelerated senescence induced by ionizing radiation in breast tumor cells. Int J Radiat Biol 2005; 81(6): 1686- 700; http://dx.doi.org/10.1080/09553000500168549
24. Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008; 76(8): 947-57; PMID: 18657518; http://dx.doi.org/10.1016/j.bcp.2008.06.024
25. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8 (4): 445-544; PMID: 22966490; http://dx.doi.org/10.4161/auto.19496
26. Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Marino G, Kepp O, Michaud M, Perfettini JL, et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signaling. Cell Death Differ 2014; 21 (1): 92-9; PMID: 24037090; http://dx.doi.org/10.1038/cdd.2013.124
27. Lai SL, Pernq RP, Hwang J. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci 2000; 7(1): 64-70; PMID: 10644891; http://dx.doi.org/10.1007/BF02255920
28. Luo ZG, Tang H, Li B, Zhu Z, Ni CR, Zhu MH. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer. Oncol Rep 2011; 25(4): 1073-81; PMID: 21286670
29. You L, Yang CT, Jablons DM. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients. Cancer Res 2000; 60(4): 1009-13; PMID: 10706117
30. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Posttranscriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 2008; 283 (49): 33911-8; PMID: 18819919; http://dx.doi.org/10.1074/jbc.M806432200
31. Hardie DG, Ross FA, Hawley SA. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13(4): 251-62; PMID: 22436748; http://dx.doi.org/10.1038/nrm3311
32. Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012; 52: 381-400; PMID: 22017684; http://dx.doi.org/10.1146/annurevpharmtox- 010611-134537
33. Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptosis stress. Autophagy 2012; 8(2): 236-51; PMID: 22240589; http://dx.doi.org/10.4161/auto.8.2.18600
34. Van Kaick G, Delorme S. Therapy induced effects in normal tissue. Radiologe 2008; 48(9): 871-80; PMID: 18709346; http://dx.doi.org/10.1007/s00117- 008-1729-3
35. Yang WL, Perillo W, Liou D, Marambaud P, Wang P. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells. J Surg Oncol 2012; 106 (6): 680-8; PMID: 22674626; http://dx.doi.org/10.1002/jso.23184
36. Cheng G, Kong D, Hou X, Liang B, He M, Liang N, Ma S, Liu X. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother Radiopharm 2013; 28(2): 153-9; PMID: 23268708; http://dx.doi. org/10.1089/cbr.2012.1297
37. Lorin S, Hamai A, Mehrpour M, and Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol 2013; 28(2): 152-9; PMID: 23811268; http://dx.doi.org/10.1016/j.semcancer.2013.06.007
38. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102(23): 8204-9.
39. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. The regulation of AMPK beta1, TSC2 and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007; 67(7): 3043-53; PMID: 17409411; http://dx. doi.org/10.1158/0008-5472.CAN-06-4149
40. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg 13-FIP200 complexes mediate mTOR signaling to autophagy machinery. Mol Biol Cell 2009; 20(7): 1992-2003; PMID: 19225151; http://dx.doi.org/10.1091/mbc. E08-12-1249
41. Gao W, Shen Z, Shang L, and Wang X. Up-regulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage- induced cell death. Cell Death Differ 2011; 18 (10): 1598-607; PMID: 21475306; http://dx.doi.org/10.1038/cdd.2011.33
42. Jeong Y, Xie Y, Lee W, Bookout AL, Girard L, Raso G, Behrens C, Wistuba II, Gadzar AF, Minna JD et al. Research Resource: Diagnostic and Therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol 2012; 26(8): 1443-1454; PMID: 22700587; http://dx.doi.org/10.1210/me.2011-1382
43. Yang YF Wu CC, Chen WP, Chen YL, Su MJ. Prazosin induces p53-mediated autophagic cell death in H9C2 cells. Naunyn Schmiedebergs Arch Pharmacol 2011; 384(2): 209-16; PMID: 21614555; http://dx.doi. org/10.1007/s00210-011-0657-3
44. Polar MK, Gennings C, Park M, Gupta MS, Gewirtz DA. Effect of vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal fibroblasts. Cancer Chemother Pharmacol 2003; 51(5): 415-21; PMID: 12690516
45. Liu Y, Shoji-Kawata S, Sumpter RM, Wei Y, Ginet V, Zhang L, Posner B, Tran KA, Green DR, Xavier RJ et al. Autosis is a NaC, KC-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A 2013; 110(51): 20364-71.
46. Overmeyer JH, Maltese WA. Death pathways triggered by activated Ras in cancer cells. Front Biosci 2011; 16: 1693-713; PMID: 21196257; http://dx.doi.org/10.2741/3814
47. Fulda S. The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther 2013; 14(11): 999-1004; PMID: 24025353; http://dx.doi.org/10.4161/cbt.26428
48. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AE, Shaw JW et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs. P16 bypass, telomerase are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66(4): 2116-28; PMID: 16489012
49. Maecker HL, Koumenis C, Giaccia AJ. P53 promotes selection for Fas-mediated apoptotic resistance. Cancer Res 2000; 60(16): 4638-44; PMID: 10969818
50. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereirasmith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92(20): 9363-7; PMID: 7568133
51. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated b-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4(12): 1798-806; PMID: 20010931; http://dx.doi.org/10.1038/nprot.2009.191
52. Menon VR, Peterson EJ, Valerie K, Farrell NP, Povirk LF. Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest. Biochem Pharmacol 2013; 86(12): 1708-20; PMID: 24161784; http://dx.doi.org/10.1016/j.bcp.2013.10.012
53. Gagou EM, Zuazua-Villar P, Meuth M. Enhanced H2Ax phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Bio Cell 2010; 21(5): 739-52; PMID: 20053681; http://dx.doi. org/10.1016/10.1091/mbc.E09-07-0618